Deck Production Management Records HUB
This page serves as the central command center for the production of LPBI Group’s 8 strategic Decks. It tracks status, key content, target audiences, and next actions for each deck. All decks are being built to support the Grok 4.20 Pivot and the overall monetization and exit strategy of the LPBI IP portfolio.
Main Content – Production Dashboard Table
Paste the table below as the core of the new page:
| # | Deck Name | Short Description / Focus | Target Audience | Key COM Parts Covered | Current Status | Next Action / Priority |
| 1 | Version A – Methodologies & Tool Factory | Core methodologies, Tool Factory (COM Parts 1–9), foundational infrastructure | Internal team, technical partners, hyperscalers | COM Parts 1–9 | Not started | Define detailed outline |
| 2 | Version B – Trainable Multimodal Data | Trainable multimodal data sets, training pipelines, data strategy | Hyperscalers, frontier modelers, AI labs | COM Part 13 + multimodal aspects of COM 10/14 | Not started | Outline data strategy |
| 3 | Version C – Emphasis on Human Signal + Expert Curation | Human-curated content, expert signal, provenance, quality control | All audiences (especially Pharma & PE/VC) | AJAUS (COM 14), Journal corpus, human-AI collaboration | Not started | Draft human-signal narrative |
| 4 | ABC: Pharma / Biotech | Pharma/biotech-specific value proposition, drug discovery, clinical applications | Pharma companies, biotech firms, CROs | COM Parts 14, 15, 16 + Journal + AJAUS | Not started | Finalize pharma-focused narrative |
| 5 | ABC: Hyperscalers and Frontier Modelers | Value proposition for hyperscalers and frontier model developers | Google, OpenAI, Anthropic, xAI, Meta, AWS, etc. | COM Parts 10–13, 14, 16 | Not started | Draft hyperscaler-specific value |
| 6 | Grok 4 aids Exit: Focus Medicine Grok 4.20 | Grok 4.20 Pivot with strong emphasis on medicine / pharma applications | xAI, Grok ecosystem partners, pharma investors | Grok 4.20 integration + COM 14/15/16 | In progress | Continue building (current priority) |
| 7 | Grok 4 aids Exit: Focus Hyperscaler Parents | Grok 4.20 Pivot tailored for hyperscalers & frontier model parents | Hyperscalers, frontier AI labs | Grok 4.20 + COM 10–13, 16 | Not started | Draft hyperscaler version |
| 8 | PE/VC, Holding Companies and Institutional Investors | Full valuation story, investment thesis, exit paths, portfolio overview | PE/VC firms, institutional investors, holding companies | All COM Parts + Valuation Framework | Not started | Integrate full valuation tables |
2012pharmaceutical
sjwilliamspa